Tenaya Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Tenaya Therapeutics Depreciation & Amortization Growth & History (TNYA)
Tenaya Therapeutics's depreciation and amortization was $8.4M for fiscal 2025.
View full Tenaya Therapeutics company overviewTenaya Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.4M | −$32,000 | −0.38% |
| 2024 | 2024-12-31 | $8.5M | −$219,000 | −2.52% |
| 2023 | 2023-12-31 | $8.7M | $2.2M | +34.33% |
| 2022 | 2022-12-31 | $6.5M | $3.5M | +118.41% |
| 2021 | 2021-12-31 | $3.0M | $478,000 | +19.25% |
| 2020 | 2020-12-31 | $2.5M | — | — |
Tenaya Therapeutics quarterly depreciation and amortization
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.7M | −$400,000 | −19.05% |
| Q1 2026 | 2026-03-31 | $1.8M | −$898,000 | −33.75% |
| Q4 2025 | 2025-12-31 | $1.8M | — | — |
| Q3 2025 | 2025-09-30 | $1.9M | −$200,000 | −9.52% |
| Q2 2025 | 2025-06-30 | $2.1M | $0 | 0.00% |
| Q1 2025 | 2025-03-31 | $2.7M | $506,000 | +23.48% |
| Q3 2024 | 2024-09-30 | $2.1M | −$100,000 | −4.55% |
| Q2 2024 | 2024-06-30 | $2.1M | −$100,000 | −4.55% |
| Q1 2024 | 2024-03-31 | $2.2M | $25,000 | +1.17% |
| Q3 2023 | 2023-09-30 | $2.2M | $100,000 | +4.76% |
| Q2 2023 | 2023-06-30 | $2.2M | $900,000 | +69.23% |
| Q1 2023 | 2023-03-31 | $2.1M | $1.2M | +120.50% |
| Q3 2022 | 2022-09-30 | $2.1M | $1.4M | +200.00% |
| Q2 2022 | 2022-06-30 | $1.3M | $600,000 | +85.71% |
| Q1 2022 | 2022-03-31 | $966,000 | $277,000 | +40.20% |
| Q3 2021 | 2021-09-30 | $700,000 | $100,000 | +16.67% |
| Q2 2021 | 2021-06-30 | $700,000 | $100,000 | +16.67% |
| Q1 2021 | 2021-03-31 | $689,000 | — | — |
| Q3 2020 | 2020-09-30 | $600,000 | — | — |
| Q2 2020 | 2020-06-30 | $600,000 | — | — |
Tenaya Therapeutics depreciation and amortization trends
Over the last five fiscal years, Tenaya Therapeutics's depreciation and amortization increased from $2.5M to $8.4M, a change of $6.0M. The latest reported quarter, Q2 2026, shows $1.7M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenaya Therapeutics source filings ↗